Skip to main content
VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc. — Investor Relations & Filings

Ticker · VYNE ISIN · US92941V1008 US Manufacturing
Filings indexed 608 across all filing types
Latest filing 2020-04-16 Major Shareholding Noti…
Country US United States of America
Listing US VYNE

About VYNE Therapeutics Inc.

https://vynetherapeutics.com/

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company's primary objective is to address unmet medical needs by advancing a pipeline of novel drug candidates. VYNE's approach centers on innovating beyond traditional assumptions to find improved solutions for patients with complex inflammatory and immunological diseases.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification
2020-04-16 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 9, 2020, by Menlo Therapeutics Inc. The key content is the announcement of the resignation of a board member and the appointment of another to the audit committee. This is a clear announcement of changes in the company's board of directors. The document does not contain financial data or detailed reports but focuses on management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3444 characters, which is typical for an 8-K filing announcing management changes. Hence, the classification is MANG with high confidence.
2020-04-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.